Shaanxi Kanghui Pharmaceutical Co Ltd - Class A

SHSE:603139 (China)   A
Â¥ 16.54 (-5.27%) May 10
At Loss
P/B:
1.74
Market Cap:
Â¥ 1.65B ($ 228.60M)
Enterprise V:
Â¥ 2.14B ($ 296.63M)
Volume:
18.86M
Avg Vol (2M):
3.97M
Volume:
18.86M
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Shaanxi Kanghui Pharmaceutical Co Ltd ( SHSE:603139 ) from 2017 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shaanxi Kanghui Pharmaceutical stock (SHSE:603139) PE ratio as of May 12 2024 is 0. More Details

Shaanxi Kanghui Pharmaceutical Co Ltd (SHSE:603139) PE Ratio (TTM) Chart

To

Shaanxi Kanghui Pharmaceutical Co Ltd (SHSE:603139) PE Ratio (TTM) Historical Data

Total 1181
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shaanxi Kanghui Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-12 At Loss 2024-03-04 At Loss
2024-05-10 At Loss 2024-03-01 At Loss
2024-05-09 At Loss 2024-02-29 At Loss
2024-05-08 At Loss 2024-02-28 At Loss
2024-05-07 At Loss 2024-02-27 At Loss
2024-05-06 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-08 At Loss
2024-04-22 At Loss 2024-02-07 At Loss
2024-04-19 At Loss 2024-02-06 At Loss
2024-04-18 At Loss 2024-02-05 At Loss
2024-04-17 At Loss 2024-02-02 At Loss
2024-04-16 At Loss 2024-02-01 At Loss
2024-04-15 At Loss 2024-01-31 At Loss
2024-04-12 At Loss 2024-01-30 At Loss
2024-04-11 At Loss 2024-01-29 At Loss
2024-04-10 At Loss 2024-01-26 At Loss
2024-04-09 At Loss 2024-01-25 At Loss
2024-04-08 At Loss 2024-01-24 At Loss
2024-04-03 At Loss 2024-01-23 At Loss
2024-04-02 At Loss 2024-01-22 At Loss
2024-04-01 At Loss 2024-01-19 At Loss
2024-03-29 At Loss 2024-01-18 At Loss
2024-03-28 At Loss 2024-01-17 At Loss
2024-03-27 At Loss 2024-01-16 At Loss
2024-03-26 At Loss 2024-01-15 At Loss
2024-03-25 At Loss 2024-01-12 At Loss
2024-03-22 At Loss 2024-01-11 At Loss
2024-03-21 At Loss 2024-01-10 At Loss
2024-03-20 At Loss 2024-01-09 At Loss
2024-03-19 At Loss 2024-01-08 At Loss
2024-03-18 At Loss 2024-01-05 At Loss
2024-03-15 At Loss 2024-01-04 At Loss
2024-03-14 At Loss 2024-01-03 At Loss
2024-03-13 At Loss 2024-01-02 At Loss
2024-03-12 At Loss 2023-12-29 At Loss
2024-03-11 At Loss 2023-12-28 At Loss
2024-03-08 At Loss 2023-12-27 At Loss
2024-03-07 At Loss 2023-12-26 At Loss
2024-03-06 At Loss 2023-12-25 At Loss
2024-03-05 At Loss 2023-12-22 At Loss

Shaanxi Kanghui Pharmaceutical Co Ltd (SHSE:603139) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Shaanxi Kanghui Pharmaceutical Co Ltd is engaged in research, development, production and sales of pharmaceutical products. It manufactures tablets, capsules, granules, oral liquids for respiratory and cold diseases, gynecological, orthopedic diseases.